Inmune Bio (INMB) Other Working Capital Changes (2018 - 2025)
Historic Other Working Capital Changes for Inmune Bio (INMB) over the last 8 years, with Q3 2025 value amounting to $176000.0.
- Inmune Bio's Other Working Capital Changes rose 21812.08% to $176000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $134000.0, marking a year-over-year increase of 11997.02%. This contributed to the annual value of -$1.2 million for FY2024, which is 5315.85% up from last year.
- Latest data reveals that Inmune Bio reported Other Working Capital Changes of $176000.0 as of Q3 2025, which was up 21812.08% from $615000.0 recorded in Q2 2025.
- In the past 5 years, Inmune Bio's Other Working Capital Changes ranged from a high of $2.4 million in Q1 2022 and a low of -$1.2 million during Q3 2023
- Over the past 5 years, Inmune Bio's median Other Working Capital Changes value was -$119000.0 (recorded in 2021), while the average stood at $40947.4.
- In the last 5 years, Inmune Bio's Other Working Capital Changes skyrocketed by 3250000.0% in 2021 and then plummeted by 203200.0% in 2024.
- Inmune Bio's Other Working Capital Changes (Quarter) stood at $978000.0 in 2021, then tumbled by 158.49% to -$572000.0 in 2022, then surged by 95.63% to -$25000.0 in 2023, then plummeted by 2032.0% to -$533000.0 in 2024, then surged by 133.02% to $176000.0 in 2025.
- Its Other Working Capital Changes stands at $176000.0 for Q3 2025, versus $615000.0 for Q2 2025 and -$124000.0 for Q1 2025.